Fengmei et al. contributed in a significant way towards the
preliminary phases of a potentially novel and effective cancer treatment
strategy with their paper titled MicroRNA-21
Down-regulates Rb1 Expression by Targeting PDCD4 in Retinoblastoma. This
outcome may not have even been the initial goal of the research project, but a
human health application of their findings could lead the way for cancer
treatment through modulation of MicroRNA in cancerous retinoblastoma cells.